7 results
IDSA Algorithm for the Initial Management of Fever and Neutropenia

LOW RISK
 • Antidpated neutropenia < 7
IDSA Algorithm for ... stable and no medical ... >7 days or • Clinically ... neutropenic #fever #IDSA ... #Algorithm #Management
IDSA Algorithm for the Management of Purulent skin and soft tissue infections (SSTIs). 
Mild infection: for
IDSA Algorithm for ... or those with clinical ... Two newer agents ... also effective agents ... #SSTIs #Algorithm
Intraoperative Anaphylaxis - Guidelines for Crises in Anaesthesia
• Unexplained hypotension
• Unexplained bronchospasm (wheeze may be absent
potential causative agents ... as patient is stable ... an appropriate critical ... possible trigger agents ... Diagnosis #Management #Workup
Causes of Secondary Hypertension - Workup and Differential Diagnosis
Approach (when evaluation should be done):
1. Severe or
Hypertension - Workup ... antihypertensive agents ... with previously stable ... 109 mm Hg) with clinical ... #Hypertension #Workup
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Any adverse events ... event, follow ACC algorithm ... Change in clinical ... Stable patients ... postoperative cardiac events
IDSA Algorithm for Neutropenic Fever - Initial Management, Subsequent Management and Prolonged Fever
Figure 1. Initial management
IDSA Algorithm for ... stable and no medical ... >7 days or • Clinically ... neutropenic #fever #IDSA ... #Algorithm #Management
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
of antifungal agents ... penetration • Variable bioavailability ... tolerable • Limited clinical ... antifungals #comparison #table